SPHK1 is a key enzyme in the sphingolipid metabolic pathway and has been widely studied in the context of cancer, cardiovascular disease, and organ fibrosis, including liver and pulmonary fibrosis (18–20). This evidence concerns the gene SPHK1 and cardiovascular disorder.